Amneal Pharmaceuticals, Llc (ky) Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Amneal Pharmaceuticals, Llc (ky) Pharmaceutical Import Records from India — 16 Products, $69.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Amneal Pharmaceuticals, Llc (ky) — Pharmaceutical Importer Profile (2026) | 16 Products, $69.8M Trade | TransData Nexus

Import Portfolio — Top 16 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Spironolactone	Diuretics	$17.4M	347	5.5%	2
2	Iron	Vitamins & Supplements	$14.9M	299	2.2%	4
3	Gabapentin	CNS & Psychiatric	$11.8M	236	1.4%	6
4	Potassium	Nutritional Supplements	$5.9M	122	0.9%	16
5	Naproxen	Analgesics & Antipyretics	$4.1M	82	3.1%	3
6	Azathioprine	Immunosuppressants	$2.9M	58	5.0%	3
7	Warfarin	Cardiovascular	$2.5M	226	20.7%	1
8	Fenofibrate	Lipid & Metabolism	$2.4M	47	3.2%	6
9	Oseltamivir	Antivirals	$2.4M	47	1.9%	4
10	Itraconazole	Antifungals	$1.9M	37	4.6%	3
11	Niacin	Lipid & Metabolism	$1.4M	36	21.9%	1
12	Doxycycline	Antibiotics	$1.0M	20	0.6%	5
13	Chloroquine	Antimalarial & Antiparasitic	$456.6K	14	0.3%	17
14	Prednisone	Respiratory	$400.0K	8	1.4%	10
15	Griseofulvin	Advanced Antifungals	$318.5K	15	0.9%	7
16	Fosfomycin	Advanced Antibiotics	$150.0K	3	1.2%	4

Amneal Pharmaceuticals, Llc (ky) imports 16 pharmaceutical products across 15 categories into United States totaling $69.8M. The company is the #1 buyer for 2 products: Warfarin, Niacin.

Amneal Pharmaceuticals, Llc (ky) — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Amneal Pharmaceuticals LLC (KY) is a U.S.-based pharmaceutical importer and buyer specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Headquartered in Bridgewater, New Jersey, Amneal operates a significant distribution and sales facility in Glasgow, Kentucky, which serves as a central hub for its logistics and customer relations. The company is a subsidiary of Amneal Pharmaceuticals, Inc., a publicly traded entity listed on the NYSE under the ticker symbol AMRX. Amneal Pharmaceuticals, Inc. is one of the largest manufacturers of generic drugs in the United States, with a diverse portfolio encompassing over 290 products across various therapeutic areas.

2Distribution Network

Amneal Pharmaceuticals LLC (KY) maintains a robust distribution network within the United States, primarily centered around its 115,000-square-foot facility in Glasgow, Kentucky. This facility consolidates distribution and sales operations, effectively serving as a critical logistics hub for the company's nationwide operations. The strategic location in Kentucky facilitates efficient distribution across the U.S., ensuring timely delivery of pharmaceutical products to various stakeholders. While the company has a significant presence in the U.S., its international distribution capabilities are not explicitly detailed in the available sources.

3Industry Role

Amneal Pharmaceuticals LLC (KY) functions as a pharmaceutical importer and buyer, focusing on sourcing finished pharmaceutical formulations from international markets, particularly India. Its role within the U.S. pharmaceutical supply chain is that of a parallel importer, facilitating the introduction of generic medications into the U.S. market. By importing these products, Amneal contributes to the diversification and availability of affordable medications, thereby enhancing competition and potentially reducing healthcare costs for consumers. The company's operations support the broader pharmaceutical distribution network by ensuring a steady supply of generic drugs to meet market demand.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Amneal Pharmaceuticals, Llc (ky)

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Amneal Pharmaceuticals LLC (KY) demonstrates a high degree of sourcing concentration, with a significant portion of its pharmaceutical imports originating from India. This strategic choice allows the company to leverage India's established pharmaceutical manufacturing capabilities, which are recognized for producing high-quality generic medications. The shipment data indicates a stable and consistent relationship with Indian suppliers, as evidenced by the total import value of $69.8 million USD across 1,597 shipments. The top five products imported—Spironolactone, Iron, Gabapentin, Potassium, and Naproxen—account for 77.6% of the total import value, highlighting a focused product portfolio. This concentration suggests that Amneal has established strong, reliable partnerships with its Indian suppliers, ensuring a steady supply of these key medications.

2Supply Chain Resilience

Amneal Pharmaceuticals LLC (KY) exhibits a resilient supply chain through its strategic sourcing from India, a country with a robust pharmaceutical manufacturing sector. The company's focus on finished pharmaceutical formulations, rather than raw APIs or bulk drugs, indicates a preference for ready-to-market products, which can expedite distribution and reduce lead times. While the available data does not specify the presence of backup suppliers or the diversity of formulations, the consistent import patterns and the company's significant investment in its Kentucky facility suggest a well-established and dependable supply chain. However, the reliance on a single source country may expose the company to risks related to geopolitical events, regulatory changes, or supply disruptions in India.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation, approval, and distribution of pharmaceutical products. The FDA enforces stringent regulations to ensure the safety, efficacy, and quality of medications available to consumers. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which outlines the standards for drug approval and importation. For Indian generics to enter the U.S. market, they must undergo the FDA's Abbreviated New Drug Application (ANDA) process, demonstrating bioequivalence to the brand-name counterpart. This regulatory framework ensures that imported generics meet the same standards as domestically produced drugs, maintaining public health and safety.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are governed by the FDA, which mandates that all imported drugs comply with U.S. regulations and standards. Manufacturers and importers must ensure that their products are produced in facilities adhering to Good Manufacturing Practice (GMP) standards recognized by the FDA. While the FDA does not have a formal list of recognized GMP certifications, it accepts certifications from reputable international bodies such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). To distribute pharmaceuticals in the U.S., companies must obtain wholesale distribution authorization from the FDA, which involves registration and compliance with specific operational standards.

Amneal Pharmaceuticals, Llc (ky) — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Amneal Pharmaceuticals LLC (KY) focuses its product strategy on importing finished pharmaceutical formulations across 16 products in 15 therapeutic categories. The top five products—Spironolactone, Iron, Gabapentin, Potassium, and Naproxen—account for a significant portion of the import value, indicating a strategic emphasis on high-demand medications. The therapeutic areas of Diuretics, Vitamins & Supplements, and CNS & Psychiatric disorders constitute the largest segments of the imported portfolio, reflecting market demand and therapeutic needs. This targeted approach allows Amneal to address prevalent health conditions and align with consumer needs, thereby enhancing its market presence and competitiveness.

2Sourcing Profile

Amneal Pharmaceuticals LLC (KY) employs a sourcing strategy that prioritizes finished pharmaceutical formulations from India, focusing on a select range of products that align with market demand and therapeutic needs. This approach enables the company to offer a diverse portfolio of generic medications, ensuring a steady supply of essential drugs to the U.S. market. By concentrating on specific therapeutic areas and products, Amneal can maintain quality control, streamline logistics, and effectively meet consumer demand. India's established pharmaceutical manufacturing sector provides a reliable source for these formulations, supporting Amneal's strategic objectives.

Market Positioning

Seller's Guide — How to Become a Supplier to Amneal Pharmaceuticals, Llc (ky)

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Amneal Pharmaceuticals LLC (KY), given the company's focus on importing finished pharmaceutical formulations from India. Potential gaps in Amneal's current sourcing include specific therapeutic areas or products not currently represented in its portfolio. Indian exporters can explore these opportunities by ensuring compliance with FDA regulations, maintaining high-quality manufacturing standards, and establishing reliable supply chains. By aligning with Amneal's product strategy and quality requirements, new suppliers can position themselves as valuable partners, contributing to Amneal's mission of providing affordable and accessible medications to the U.S. market.

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Amneal Pharmaceuticals, Llc (ky)

What products does Amneal Pharmaceuticals, Llc (ky) import from India?

Amneal Pharmaceuticals, Llc (ky) imports 16 pharmaceutical products across 15 categories. Top imports: Spironolactone ($17.4M), Iron ($14.9M), Gabapentin ($11.8M), Potassium ($5.9M), Naproxen ($4.1M).

What is Amneal Pharmaceuticals, Llc (ky)'s total pharmaceutical import value?

Amneal Pharmaceuticals, Llc (ky)'s total pharmaceutical import value from India is $69.8M, based on 1,597 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Amneal Pharmaceuticals, Llc (ky) focus on?

Amneal Pharmaceuticals, Llc (ky) imports across 15 categories. The largest: Diuretics (24.9%), Vitamins & Supplements (21.4%), CNS & Psychiatric (16.9%).

Get Full Amneal Pharmaceuticals, Llc (ky) Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Amneal Pharmaceuticals, Llc (ky)

Amneal Pharmaceuticals, Llc (ky) — Import Portfolio & Supplier Network

What Products Does Amneal Pharmaceuticals, Llc (ky) Import?

Top Products by Import Value

Amneal Pharmaceuticals, Llc (ky) Therapeutic Categories — 15 Specializations